HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Firm” or “HAVN Life“) pronounces that the board of administrators of the Firm (the “Board“), on the recommendation of the Firm’s Chief Monetary Officer, has decided that the Firm is not a going concern as it’s unable to fulfill its monetary obligations as they arrive due.
A restructuring plan is being put collectively by the Board, and the Firm is actively pursuing financing. There is no such thing as a assurance that the restructuring might be profitable or that the Firm will be capable to safe a brand new supply of financing.
About HAVN Life Sciences Inc.
HAVN Life Sciences is a biotechnology firm pursuing standardized extraction of psychedelic compounds for the creation of APIs, the event of pure well being merchandise, and progressive therapies to help mind well being.
By way of its analysis division, HAVN Labs, the corporate has developed an end-to-end provide chain of standardized, naturally derived psychedelic compounds for analysis that can outline the way forward for fashionable medication. With its new line of pure well being merchandise, HAVN Life presents a full vary of high-quality mushroom and plant extracts that assist increase immune perform, scale back irritation and help a wholesome life-style.
Buy our merchandise and discover out extra at yourhavnlife.com, and comply with us on Fb, Twitter, Instagram and Youtube.
Ahead-Wanting Info: This information launch accommodates “forward-looking info” throughout the that means of relevant securities legal guidelines referring to statements relating to the restructuring plan, together with, with out limitation, pursuit of future financings, the Firm’s enterprise, merchandise and way forward for the Firm’s enterprise. Though the Firm believes that the expectations mirrored within the forward-looking info are affordable, there will be no assurance that such expectations will show to be appropriate. Readers are cautioned to not place undue reliance on forward-looking info. Such forward-looking statements are topic to dangers and uncertainties that will trigger precise outcomes, efficiency and developments to vary materially from these contemplated by these statements relying on, amongst different issues, the danger that the Firm won’t be able to impact the restructuring plan, together with, with out limitation, get hold of future financing(s), that the Firm won’t be able to ever set up its operations as a going concern, and that the plans will range from these said on this information launch and the Firm could not be capable to perform its enterprise plans as anticipated. Different elements, which might materially have an effect on such forward-looking info are described within the danger elements within the Firm’s most up-to-date administration’s dialogue and evaluation and annual info kind, which can be found on the Firm’s profile on SEDAR at sedar.com. Readers are cautioned that the foregoing record of things will not be exhaustive. The forward-looking statements included on this information launch are expressly qualifying by this cautionary assertion. The forward-looking statements and knowledge contained on this information launch are made as of the date hereof and besides as required by regulation, the Firm expressly disclaims any obligation and doesn’t intend to replace any forward-looking statements or forward-looking info on this information launch. Though the Firm believes that the expectations mirrored within the forward-looking info are affordable, there will be no assurance that such expectations will show to be appropriate. The statements on this information launch are made as of the date of this launch.